Scientific article
French

Le concept de "resistance" a l'aspirine: mecanismes et pertinence clinique

Other title

The concept of aspirin "resistance": mechanisms and clinical relevance

Published in

La Revue de médecine interne, vol. 30, no. 12, p. 1020-1029

Publication date

2009

Abstract

Aspirin, a 110-year-old molecule, is a cornerstone in the treatment of atherothrombotic patients. The concept of aspirin "resistance" emerged approximately 15 years ago and is of growing interest. Aspirin resistance, defined as a lack of inhibition of cyclo-oxygenase-1 (COX-1), is a rare phenomenon and its clinical relevance can hardly be studied. On the contrary, residual platelet hyperactivity is more common and affects 20 to 30% of aspirin-treated patients. This latter phenomenon corresponds to sustained platelet reactivity despite a proper inhibition of COX-1 by aspirin. Several meta-analyses suggest that residual platelet hyperactivity could be a risk factor for the recurrence of ischemic events in aspirin-treated patients. Causes of biological non-responsiveness to aspirin are discussed, including the role of compliance, drug-drug interactions, genetic polymorphisms and diabetes mellitus. Ongoing studies are designed to find out the mechanisms of residual platelet hyperactivity, determine its potential clinical relevance and delineate the more appropriate assays in order to identify patients who may benefit of a tailored antiplatelet therapy.

Keywords

  • Aspirin/administration & dosage/pharmacology
  • Cardiovascular Diseases/genetics/prevention & control
  • Cyclooxygenase 1/drug effects/genetics
  • Cyclooxygenase Inhibitors/administration & dosage/pharmacology
  • Drug Resistance/genetics
  • Humans
  • Meta-Analysis as Topic
  • Myocardial Ischemia/etiology
  • Platelet Aggregation Inhibitors/administration & dosage/pharmacology
  • Polymorphism, Genetic
  • Recurrence
  • Risk Factors
  • Thrombosis/genetics/prevention & control

Citation (ISO format)

RENY, Jean-Luc et al. Le concept de ‘resistance’ a l’aspirine: mecanismes et pertinence clinique. In: La Revue de médecine interne, 2009, vol. 30, n° 12, p. 1020–1029. doi: 10.1016/j.revmed.2009.02.028

Main files (1)

Article (Published version)

Identifiers

Journal ISSN

0248-8663
576views
0downloads

Technical informations

Creation

23/04/2012 13:24:56

First validation

23/04/2012 13:24:56

Update

13/02/2026 14:54:59

Status update

13/02/2026 14:54:59

Last indexation

28/09/2026 12:16:30
All rights reserved by Archive ouverte UNIGE and the University of Geneva
OpenAIRE Indexed & Validated